A review of traditional Chinese medicine Curcumae Rhizoma for treatment of glioma.
Curcumae Rhizoma
Curcumin
Curcumol
Glioma
Traditional Chinese medicine
β-Elemene
Journal
International review of neurobiology
ISSN: 2162-5514
Titre abrégé: Int Rev Neurobiol
Pays: United States
ID NLM: 0374740
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
1
11
2023
pubmed:
14
10
2023
entrez:
13
10
2023
Statut:
ppublish
Résumé
Glioma is the most common primary central nervous tumor and its malignant and high recurrence rate are seriously threatening patient's life. The prognosis of glioma patients is still poor with a variety of modern treatments. Traditional Chinese medicine (TCM) is widely used in the adjuvant treatment or alternative medicine of glioma. Curcumae Rhizoma is one of the most commonly used in traditional Chinese medicine prescriptions for its anti-tumor characteristics. There are also many studies that reveals the anti-tumor effect of its active ingredients and some of which have been made into drugs and have been used in clinical practice. This review summarizes the new research progress on Curcumae Rhizoma for the treatment of glioma in recent years.
Identifiants
pubmed: 37833016
pii: S0074-7742(23)00065-X
doi: 10.1016/bs.irn.2023.07.004
pii:
doi:
Substances chimiques
Drugs, Chinese Herbal
0
Types de publication
Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
303-319Informations de copyright
Copyright © 2023. Published by Elsevier Inc.